Whole genome and whole transcriptome genomic profiling of a metastatic eccrine porocarcinoma

[1]  Steven J. M. Jones,et al.  Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline CHEK2:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinoma , 2017, Cold Spring Harbor molecular case studies.

[2]  Benjamin J. Raphael,et al.  Integrated genomic characterization of oesophageal carcinoma , 2017, Nature.

[3]  Steven J. M. Jones,et al.  Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non–small Cell Lung Cancer , 2016, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[4]  Jianchun Chen,et al.  Expression and Function of the Epidermal Growth Factor Receptor in Physiology and Disease. , 2016, Physiological reviews.

[5]  S. Tomlins,et al.  Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations. , 2016, Human pathology.

[6]  Ricardo Villamarín-Salomón,et al.  ClinVar: public archive of interpretations of clinically relevant variants , 2015, Nucleic Acids Res..

[7]  M. Furue,et al.  Immunohistological Expression of p16INK4a is Commonly Present Both in Benign and Malignant Sweat Gland Neoplasias. , 2015, Fukuoka igaku zasshi = Hukuoka acta medica.

[8]  P. Visca,et al.  Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer , 2015, Cell Death and Disease.

[9]  M. Stratton,et al.  High burden and pervasive positive selection of somatic mutations in normal human skin , 2015, Science.

[10]  E. Guevara-Gutiérrez,et al.  Eccrine porocarcinoma: epidemiologic and histopathologic characteristics , 2015, International journal of dermatology.

[11]  Mingming Jia,et al.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..

[12]  N. Al-Rawi,et al.  PIK3CB and K-ras in oral squamous Cell carcinoma. A possible cross-talk! , 2014 .

[13]  Steven J. M. Jones,et al.  Diagnostic value of next-generation sequencing in an unusual sphenoid tumor. , 2014, The oncologist.

[14]  M. Kadakia,et al.  Pten loss induces autocrine FGF signaling to promote skin tumorigenesis. , 2014, Cell reports.

[15]  T. Miller,et al.  Therapeutic targeting of cancers with loss of PTEN function. , 2014, Current drug targets.

[16]  A. Goldstein,et al.  The genetics of melanoma: recent advances. , 2013, Annual review of genomics and human genetics.

[17]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[18]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[19]  Heng Li.  Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[20]  Thomas Wiesner,et al.  Tumours associated with BAP1 mutations , 2013, Pathology.

[21]  A. Bashashati,et al.  Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer , 2012, Genome research.

[22]  Wendy S. W. Wong,et al.  Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..

[23]  Gholamreza Haffari,et al.  Feature-based classifiers for somatic mutation detection in tumour–normal paired sequencing data , 2011, Bioinform..

[24]  Süleyman Cenk Sahinalp,et al.  deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data , 2011, PLoS Comput. Biol..

[25]  A. Iafrate,et al.  A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas , 2011, Modern Pathology.

[26]  Steven J. M. Jones,et al.  De novo assembly and analysis of RNA-seq data , 2010, Nature Methods.

[27]  Steven J. M. Jones,et al.  Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors , 2010, Genome Biology.

[28]  S. Devesa,et al.  Cutaneous appendageal carcinoma incidence and survival patterns in the United States: a population-based study. , 2010, Archives of dermatology.

[29]  Inanç Birol,et al.  De novo transcriptome assembly with ABySS , 2009, Bioinform..

[30]  Yu-Ying He,et al.  PTEN: new insights into its regulation and function in skin cancer. , 2009, The Journal of investigative dermatology.

[31]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[32]  Steven J. M. Jones,et al.  Abyss: a Parallel Assembler for Short Read Sequence Data Material Supplemental Open Access , 2022 .

[33]  N. Gotoh.  Feedback inhibitors of the epidermal growth factor receptor signaling pathways. , 2009, The international journal of biochemistry & cell biology.

[34]  E. Wolf,et al.  The epidermal growth factor receptor ligands at a glance , 2009, Journal of cellular physiology.

[35]  S. Chimenti,et al.  Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers , 2007, The British journal of dermatology.

[36]  Nan Hu,et al.  High frequency of CDKN2A alterations in esophageal squamous cell carcinoma from a high‐risk Chinese population , 2004, Genes, chromosomes & cancer.

[37]  T. Liloglou,et al.  Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin , 2003, The British journal of dermatology.

[38]  T. Mak,et al.  Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. , 2003, Cancer research.

[39]  M. Takata,et al.  Genetic changes in sweat gland carcinomas , 2000, Journal of cutaneous pathology.

[40]  G. Hannon,et al.  Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers. , 1995, Human molecular genetics.

[41]  C. Lawson,et al.  2. Analysis of the Least Squares Problem , 1995 .